Neurometrix nce 35% tom qab tau txais FDA Breakthrough Designation rau nws Quell tech

NeuroMetrix Inc. (NASDAQ: NURO) tua 35% tom qab tshaj tawm tias FDA tau muab tsub rau nws Breakthrough Device Designation rau nws Quell technology. Cov thev naus laus zis tshiab no yog tsim los pab txo cov tsos mob hnyav mus rau nruab nrab chemo uas tseem nyob ntev li rau lub hlis tom qab ib tus ua tiav nrog chemo. 

Yuav luag 650,000 tus neeg tawm tsam mob qog noj ntshav tau txais tshuaj kho mob txhua xyoo hauv Tebchaws Meskas ib leeg. Chemotherapy-induced peripheral neuropathy, los yog CIPN luv luv, yog ib qho kev kho mob tsis txaus ntseeg uas muaj nyob rau hauv cov neeg mob feem ntau siv cov tshuaj kws khomob, xws li cisplatin, paclitaxel, thiab vincristine.

CIPN yog dab tsi?

Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?

Sau npe rau Invezz cov ntawv xov xwm, hnub no.

Rau qhov pib, cov tsos mob ntawm CIPN muaj xws li loog, cramping, tingling, thiab ib tug tua / hlawv mob ntawm koj txhais tes thiab ko taw. Cov mob no tseem cuam tshuam rau kev ua neej tsis zoo thiab kev tshuav nyiaj li cas. Kwv yees li 30% ntawm cov neeg mob qog noj ntshav yuav tsum tau ua rau mob ntev lossis hnyav CIPN.

Qhov no txhais tau hais tias lawv tiv taus cov tsos mob ntev li peb mus rau rau lub hlis tom qab lawv tau ua tiav nrog lawv cov kev kho mob.

Chemotherapy-induced peripheral neuropathy tsis muaj kev kho mob uas tau pom zoo los ntawm FDA, thiab cov neeg nyob hauv khw muaj kev phiv thiab kev ua haujlwm tsawg. 

Paub meej txog Quell

Neurometrix 'Quell khoom yog ib qho kev tshaj lij, neuromodulation, tsis yog-tus tech uas tau them los ntawm txog kaum cuaj lub tebchaws United States patents. Nws yog ib qho hnav khaub ncaws neuromodulator uas tau siv los ntawm microchip cov cuab yeej uas muaj lub zog siab, cov paj hlwb meej. 

Lub Quell thev naus laus zis siv cov lus tsa suab thiab kev hnov ​​​​lub luag haujlwm los kho qhov stimulation rau qhov ua tau zoo tshaj plaws nyob rau nruab hnub thiab hmo ntuj. Tsis tas li ntawd, koj tuaj yeem siv nws lub zog qis Bluetooth los sib txuas lus nrog smartwatch thiab smartphone daim ntawv thov uas pab cov neeg mob qog noj ntshav tswj thiab kho lawv tus kheej. 

Lub Breakthrough Device Designation program los ntawm FDA yog tsim los pab cov neeg mob qog noj ntshav tau yooj yim dua thiab nkag mus rau kev siv thev naus laus zis uas tuaj yeem muab kev kuaj mob zoo dua lossis kev kho mob rau qhov tsis muaj kev cuam tshuam lossis kev phom sij rau lub neej thiab kab mob. 

Raws li qhov kev pab cuam tsim los ntawm FDA, Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj yuav muab Neurometrix Inc kev sib tham sib tham thiab tshuaj xyuas qhov tseem ceeb cuam tshuam nrog kev txhim kho cov cuab yeej.

Cov ntaub ntawv xa los ntawm lub tuam txhab hauv kev txhawb nqa ntawm qhov kev pab cuam tsim los ntawm FDA suav nrog kev tshawb pom los ntawm kev qhib-daim ntawv sau npe, kev kawm rau lub lim tiam uas txheeb xyuas qhov ua tau zoo thiab kev nyab xeeb ntawm Quell thev naus laus zis thaum siv hauv tsev los kho cov neeg mob qog noj ntshav tawm tsam CIPN.